
Sign up to save your podcasts
Or


Health Affairs' Editor-in-Chief Alan Weil interviews Janice Jhang of Harvard University about her recent paper that explores how regulatory and market forces are driving adoption of biosimilars.
Order the November 2024 issue of Health Affairs.
Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.
By Health Affairs4.9
4141 ratings
Health Affairs' Editor-in-Chief Alan Weil interviews Janice Jhang of Harvard University about her recent paper that explores how regulatory and market forces are driving adoption of biosimilars.
Order the November 2024 issue of Health Affairs.
Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.

43,853 Listeners

32,245 Listeners

6,963 Listeners

30,693 Listeners

7,702 Listeners

499 Listeners

7,255 Listeners

1,078 Listeners

16,474 Listeners

390 Listeners

630 Listeners

29 Listeners

16,487 Listeners

68 Listeners

614 Listeners